Pharmaceutical/healthcare primer

Hi everyone,

I am a 1st year healthcare analyst from a finance background. Basically know nothing about healthcare but was staffed with our healthcare team. 

Wondering if there is a primer/bible addressing pharmaceutical/healthcare sector? It would be great to learn more about different subsectors like prescription drugs, OTC, brand name drugs, generic drugs, biopharma, etc. and valuation methods.

I realize it is a big ask. I would be grateful if anyone could provide suggestions. My bank has database subscriptions so I could also look into helpful reports.

Thanks in advance.

 

From my experience, there isn't really a primer addressing the sector for many good reasons. The sector is always changing, with innovation, new regulations, new subsidies etc. It is quite difficult to create a primer than is still relevant 1/2/3 years down the road. Might be worth looking into individual research papers addressing a specific issue of healthcare such as pricing and speaking to colleagues who have worked on a certain aspect of healthcare. I would say it is mostly on the job experience rather than being able to simply "read and become an expert". 

 

There is an old DB equity research primer on pharma that covers development, lifecycle… probably from 2012-2013 but golden. You’ll find it on Thomsonone or equivalent with a bit of effort.

Cs had decent CRO coverage a little while back and good sector notes

Rbc initiated cdmos sector last year

Cowen have great thematic reports for pharma / biotech - more advanced and technology focused though.

Gsk spin-off Haleon earlier his year has been covered by all major firms - have a look at initiations for a good OTC read

Alcon spun off from novartis was a major medtech listing, check initiations.

Oxford nanopore IPO for life science / tools. Some good reports from Cowen on this sector too, and also diagnostics.

Siemens healthineers 2018 IPO for some good capital equipment / diagnostics initiations

 

Nam non repellat ratione dolorum dignissimos. Impedit quia recusandae et quia sint similique. Expedita iure ut voluptatem consectetur.

At quas explicabo aut nemo consequatur eum. Animi dolores velit exercitationem sunt. Aut placeat unde occaecati iure nam. Deserunt est eos soluta eaque officiis. Adipisci perspiciatis labore non aliquam ut itaque.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
CompBanker's picture
CompBanker
98.9
6
kanon's picture
kanon
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”